Keros Therapeutics Inc (KROS) net margin is -2.6%
Keros Therapeutics Inc (KROS) net margin is -2.6% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full KROS research page for quote, filings, and the rest of the model. This satellite exists so “Keros Therapeutics Inc net margin” can rank with the actual number, then send you to /stock/kros.